DEPARTMENT OF JUSTICE, DRUG ENFORCEMENT ADMINISTRATION, CONTRACT SERVICES SECTION, WASHINGTON, D.C. 20537

Q -- LABORATORY TESTING ANALYSIS SERVICES SOL DEA-95-R-0022 DUE 060695 POC Doreen Upshur, Contract Specialist, 202-307-7806; ; The Drug Enforcement Administration (DEA) intends to contract with American Medical Laboratories (AML), Fall Church, VA. for laboratory services. AML will analyze industrial hygiene samples and blood and urine samples from the DEA laboratory employees for chloroform, methylene chloride, controlled substances, and other hazardous materials. The following test will be conducted at a sensitivity level of 1-10 parts per billion (PPB) for the drug levels, and 100-500 PPB for the chlorinated solvents. These sensitivity levels fill require the use of an election capture detector on a gas chromatograph spectrometer (GC-MS) a. Air Samples for drug mixture from filter cassettes. (GC-MS) b. Wipe Samples for drug mixtures (GC-MS). c. Analysis of characoal tubes for the solvents. d. Gravimetric Analysis e. Metats by Atomic Absorption (AA). Contractors are required to provide sufficient information that shall demonstrate their capability to perform analysis of blood sample for the following solvents at the indicated threshold using chromatograph-mass spectrometry; solvents GC-MS (nanograms per milliter (NG/ML); chlorinated solvents to include chloroform 1.0, methylene chloride 1.0, aromatic hydrocarbon to include: benzene 1.0, toluene 1.0, xylene 1.0, aliphatic hydrocarbons to include: heptane 1.0 hexane 1.0 additional solvents to include: methyl ether ketone 1.0 and ether 1.0 contractor shall provide proof of accreditation by the National Institute of Drug Abuse and Drug Enforcement Administration for handling controlled substances. Contractor shall provide proof of demonstrated capability in processing blood and urine, and shall demonstrate procedures for forensic chain-of-custody sample control and have a certified forensic toxicologist on staff. Capability statements should also include the ability to analyze, collect specimens using either emit or radioimmunoassay (RIA) at various levels of detection with all positives confirmed using gas-chromatography-mass spectrometry (GS-MS), also at various levels of detection. Contractor shall provide proof of capability to perform analysis of urine samples for the following drugs of abuse at various levels using emit: amphetamines, cocaine and benzoylecgonine. Contractor shall provide proof of capability to perform analysis of urine samples for the following drugs of abuse at various level using radioimmunoassay (RAI): amphetamines, cocaine and benzoylecgonine, phencyclidine, THC, opiates, methaqualone, benzodiazephine and LSD. Contractor shall provide proof of capability to perform analysis of urine samples for the following drugs of abuse at various levels using gas-chromatography-mass-spectrometry (GC-MS) amphetamines, cocaine and benzoylecgonine with 3 positive ions, phencyclidine, THC, opiates, methaqualone, benzodiazopine and anabolic steroids. AML is the only known source with procedures in place for analyzing each type of sample at the required level sensitivity. This acquisition with be pursued pn a sole source basis. All responsible sources may submit a proposal which shall be considered by the agency. Only written requests for solicitation will be accepted. Responses shall be submitted to Ms. Doreen Upshur at the above address. Any hand carried or express mail responses are to be delivered to the Drug Enforcement Administration, 700 Army Navy Drive, Arlington, VA. 22202. Attn: Doreen Upshur, See Numbered Note 22. (0138)

Loren Data Corp. http://www.ld.com (SYN# 0043 19950519\Q-0001.SOL)